Monkeypox 2003 U.S. Outbreak

Monkeypox virus represents a double-stranded DNA virus of the genus Orthopoxvirus, genetically distinct from other viruses in this group - including variola virus (the cause of smallpox) and vaccinia virus (the virus used for the smallpox vaccine).

Human monkeypox was initially identified in the Democratic Republic of Congo (Zaire) in 1970, near the end of smallpox eradication efforts in Africa. Transmission of the disease is primarily by large droplets or direct contact, and the symptoms are similar to those of smallpox, albeit usually milder.

The outbreak of monkeypox in the US Midwest during June 2003 was identified as the first documented human infection in the Western Hemisphere. In concordance with the outbreaks in Africa, a majority of cases were presented with febrile rash illness.

The development of the outbreak

On April 9, 2003, a shipment of 812 small mammals from the city Accra in Ghana was received by a Texas animal distributor. This included rope squirrels (Funisciurus pyrropus), sun squirrels (Heliosciurus gambianus), African dormice (Graphariurus spp.) and giant Gambian rats (Cricetomys spp.).

Twelve days later, an Illinois vendor received the animals from the Texas distributor. An infected Gambian rat was housed together with captive prairie dogs (Cynomys spp.) that this vendor later distributed to six different states in the US. These animals were considered to be a primary source of this outbreak, as most of the infected people became sick after contact with pet prairie dogs.

On May 15, physicians reports started to emerge from the Midwest, describing people who were exhibiting symptoms similar to smallpox, although less contagious and in milder form. Affected individuals became ill with a fever, respiratory symptoms and swollen lymph nodes. A rash developed with progression into vesicles and spread across the body, with eventual formation of crusts and scabs. The illness lasted between 2 and 4 weeks.

Over the next couple of weeks, outbreaks of monkeypox were identified in Wisconsin, Indiana and Illinois, i.e. in the countries where the Texas distributor has sent prairie dogs to pet dealers. Although the route of transmission to humans was from close contact with infected mammalian pets, human-to-human transmission may have also occurred. The last case was reported on June 20.

The impact of the outbreak

Of 72 reported cases, 37 human cases were laboratory confirmed as human monkeypox during 2003 US outbreak. Electron microscopy and serologic studies were methods used to confirm the correct diagnosis. Most cases were associated with a mild, self-limited febrile rash illness and it is important to note that there were no deaths.

Of the patients from whom the data was available, 18 were hospitalized, although some due to isolation precautions only. Two patients (both children) had serious clinical illness – the first child presented with severe encephalitis, while the second child exhibited profound and painful cervical and tonsilar lymphadenopathy with diffuse pox lesions.

Introduction of exotic species (such as rodents from Africa) still represents a significant public health threat because of the potential infection with monkeypox virus, but also with other nonindigenous pathogens. Therefore all health-care providers, veterinarians and public health officials who suspect monkeypox in animals or humans are obliged to report such cases to their state or local health departments.

Sources

  1. http://www.who.int/mediacentre/factsheets/fs161/en/
  2. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5223a1.htm
  3. http://cid.oxfordjournals.org/content/58/2/260.long
  4. http://cid.oxfordjournals.org/content/41/12/1765.long
  5. Fenner F. Human Monkeypox, A Newly Discovered Human Virus Disease. In: Morse S. Emerging Viruses. Oxford University Press, 1993; pp. 176-183.

Last Updated: Aug 23, 2018

Dr. Tomislav Meštrović

Written by

Dr. Tomislav Meštrović

Dr. Tomislav Meštrović is a medical doctor (MD) with a Ph.D. in biomedical and health sciences, specialist in the field of clinical microbiology, and an Assistant Professor at Croatia's youngest university - University North. In addition to his interest in clinical, research and lecturing activities, his immense passion for medical writing and scientific communication goes back to his student days. He enjoys contributing back to the community. In his spare time, Tomislav is a movie buff and an avid traveler.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Meštrović, Tomislav. (2018, August 23). Monkeypox 2003 U.S. Outbreak. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/Monkeypox-2003-US-Outbreak.aspx.

  • MLA

    Meštrović, Tomislav. "Monkeypox 2003 U.S. Outbreak". News-Medical. 31 October 2024. <https://www.news-medical.net/health/Monkeypox-2003-US-Outbreak.aspx>.

  • Chicago

    Meštrović, Tomislav. "Monkeypox 2003 U.S. Outbreak". News-Medical. https://www.news-medical.net/health/Monkeypox-2003-US-Outbreak.aspx. (accessed October 31, 2024).

  • Harvard

    Meštrović, Tomislav. 2018. Monkeypox 2003 U.S. Outbreak. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/Monkeypox-2003-US-Outbreak.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single dose of MVA-BN vaccine shows 58% effectiveness against mpox